Title:
USE OF DEXMEDETOMIDINE FOR ICU SEDATION
Document Type and Number:
WIPO Patent Application WO1999049854
Kind Code:
A3
Abstract:
The present invention relates to a method of sedating a patient while in the intensive care unit (ICU). The method comprises administering dexmedetomidine or a pharmaceutically acceptable salt thereof to a patient in need thereof for a sufficient time period. Further, the present invention relates to a method of sedating a patient in the ICU by administering dexmedetomidine or a pharmaceutically acceptable salt thereof, wherein dexmedetomidine is essentially the sole active agent or the sole active agent.
More Like This:
Inventors:
AANTAA RIKU (FI)
BACHAND ROMEO (US)
HEINONEN ESA (FI)
BACHAND ROMEO (US)
HEINONEN ESA (FI)
Application Number:
PCT/FI1999/000266
Publication Date:
November 18, 1999
Filing Date:
March 31, 1999
Export Citation:
Assignee:
ORION CORP (FI)
ABBOTT LAB (US)
AANTAA RIKU (FI)
BACHAND ROMEO (US)
HEINONEN ESA (FI)
ABBOTT LAB (US)
AANTAA RIKU (FI)
BACHAND ROMEO (US)
HEINONEN ESA (FI)
International Classes:
A61K31/4174; C07D233/58; A61P25/04; A61P25/20; A61P25/22; A61P43/00; (IPC1-7): A61K31/415
Foreign References:
| EP0413487A1 | 1991-02-20 | |||
| EP0424059A1 | 1991-04-24 |
Other References:
BISCHOFF P. ET AL: "[Alpha2-agonists in anaesthesia and intensive - care medicine]. ALPHA2-AGONISTEN IN ANASTHESIE UND INTENSIVMEDIZIN.", ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, (1993) 28/1 (2-12). ISSN: 0939-2661 CODEN: AISTE5, Germany, XP002109241
CRIPPEN D. ET AL: "Stress, agitation, and brain failure in critical care medicine.", CRITICAL CARE NURSING QUARTERLY, (1992) 15/2 (52-74). ISSN: 0887-9303 CODEN: CCNQEJ, United States, XP002109242
CRIPPEN D. ET AL: "Stress, agitation, and brain failure in critical care medicine.", CRITICAL CARE NURSING QUARTERLY, (1992) 15/2 (52-74). ISSN: 0887-9303 CODEN: CCNQEJ, United States, XP002109242
Download PDF: